ISSAQUAH, Wash.--(BUSINESS WIRE)-- Highlighting an impressive array of new products, Spacelabs Healthcare will present its extensive collection of perioperative solutions at the American Society of Anesthesiologists’ annual meeting, October 13-17 in Washington, DC.
At the forefront will be the new, high-performance ARKONTM anesthesia delivery system, designed to allow the anesthesiologist to focus more on the patient – thanks to innovative technology and unique enhancements – along with a flexible and ergonomic design that conforms to the way the anesthesiologist works. Spacelabs’ versatile and reliable BleaseFocus and BleaseSirius anesthesia systems will also be on display, along with the recently released Multigas Module that is suitable for use on all patient populations.
Two new patient monitors from Spacelabs’ Art of Monitoring portfolio – the compact qubeTM and the sleek XPREZZONTM – will provide vital patient information to Spacelabs’ renowned ICS G2 Clinical Access application, for access when and where it is needed. Spacelabs will also show XPREZZON’s optional dual display which allows the anesthesiologist to view lab results or radiology reports for example, on one display, while the other display remains dedicated to the patient’s real-time physiologic waveforms and alarms.
"At the ASA, anesthesiologists will see that from low to high acuity and simple to complex procedures, Spacelabs solutions can be configured to suit the patient’s needs as well as the anesthesiologist’s preferences," said Nicholas Ong, President of Spacelabs Healthcare.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Bruce Dammann, 425-657-7200 x4005
Source: Spacelabs Healthcare